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Current Therapeutic Research
VOLUME , NUMBER , JUNE CorrectionIn the article by T. Teramoto et al, titled “Cross-Sectional Survey to Assess the Status
of Lipid Management in High-Risk Patients With Dyslipidemia: Clinical Impact of
Combination Therapy With Ezetimibe,” in the February/April 2012 issue, there were
some errors in the tables. In Table II, on page 7, the unit of measure in the “Therapy”
column should have correctly appeared as: mg/dL. In Table III, on page 10, the unit
of measure in the asterisked footnote under the table should have correctly appeared
as: mg/dL. Corrected versions of these tables appear below.
The corrections mentioned in this erratum have also been made to the article
online.
http://dx.doi.org/10.1016/j.curtheres.2012.04.001
Table II. Number of patients treated with each lipid-lowering agent.
Therapy
Primary Prevention
High-Risk Group
Secondary Prevention
Group Total
tatin monotherapy,
No. (%) [dose,
mean (SD), mg/dL]
Pravastatin 170 (21.5) [8.5 (2.3)] 83 (19.8) [9.0 (2.0)] 253
Simvastatin 30 (3.8) [5.8 (1.9)] 46 (11.0) [5.5 (1.6)] 76
Fluvastatin 58 (7.3) [23.4 (6.9)] 21 (5.0) [22.0 (6.8)] 79
Atorvastatin 236 (29.8) [8.3 (2.4)] 107 (25.5) [9.0 (2.1)] 343
Pitavastatin 125 (15.8) [1.6 (0.5)] 57 (13.6) [1.8 (0.4)] 182
Rosuvastatin 172 (21.7) [3.0 (1.0)] 106 (25.2) [3.1 (1.1)] 278
Subtotal 791 420 1211
ombination therapy,
No. (%)
Ezetimibe 210 (73.9) 174 (77.3) 384
Eicosapentaenoic
acid
38 (13.4) 23 (10.2) 61
Bezafibrate 22 (7.7) 14 (6.2) 36
Fenofibrate 8 (2.8) 5 (2.2) 13
Colestimide 1 (0.4) 6 (2.7) 7
Probucol 4 (1.4) 2 (0.9) 6
Nicotinic acid 1 (0.4) 1 (0.4) 2
Subtotal 284 225 509121
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Therapy
Primary Prevention High-Risk
Group Secondary Prevention Group
Total
No. of
Patients
Patients
Achieving
Goal, No.*
Achieving-
Goal
Rate, %
Total
No. of
Patients
Patients
Achieving
Goal, No.†
Achieving-
Goal
Rate, %
Ezetimibe 210 113 53.8 174 111 63.8
Eicosapentaenoic
acid
38 10 26.3 23 4 17.4
Bezafibrate 22 1 4.5 14 2 14.3
Fenofibrate 8 2 25.0 5 0 0
Colestimide 1 0 0 6 2 33.3
Probucol 4 4 100 2 0 0
Nicotinic acid 1 1 100 1 0 0
Total 284 131 46.1 225 119 52.9
*Goal is an LDL-C level 120 mg/dL (to convert to millimoles per liter, multiply by 0.0259).
†Goal is an LDL-C level 100 mg/dL.
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